Advanced search
Publication Cover
OncoImmunology Volume 6, 2017 - Issue 9
Submit an article Journal homepage
2,222
Views
37
CrossRef citations to date
0
Altmetric
Original Research

Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4

Nathalie Rouas-FreissCEA, Direction de la Recherche Fondamentale (DRF), Service de Recherche en Hemato-Immunologie (SRHI), Paris, France;Universite Paris Diderot, Sorbonne Paris Cite, IUH, Hopital Saint-Louis, UMR_E5, Paris, France
,
Joel LeMaoultCEA, Direction de la Recherche Fondamentale (DRF), Service de Recherche en Hemato-Immunologie (SRHI), Paris, France;Universite Paris Diderot, Sorbonne Paris Cite, IUH, Hopital Saint-Louis, UMR_E5, Paris, France
,
Jérôme VerineCEA, Direction de la Recherche Fondamentale (DRF), Service de Recherche en Hemato-Immunologie (SRHI), Paris, France;Universite Paris Diderot, Sorbonne Paris Cite, IUH, Hopital Saint-Louis, UMR_E5, Paris, France;Service d'Anatomo-Pathologie, AP-HP, Hopital Saint-Louis, Paris, France
,
Diana Tronik-Le RouxCEA, Direction de la Recherche Fondamentale (DRF), Service de Recherche en Hemato-Immunologie (SRHI), Paris, France;Universite Paris Diderot, Sorbonne Paris Cite, IUH, Hopital Saint-Louis, UMR_E5, Paris, France
,
Stéphane CulineCEA, Direction de la Recherche Fondamentale (DRF), Service de Recherche en Hemato-Immunologie (SRHI), Paris, France;Universite Paris Diderot, Sorbonne Paris Cite, IUH, Hopital Saint-Louis, UMR_E5, Paris, France;Service d'Oncologie Médicale, AP-HP, Hopital Saint-Louis, Paris, France
,
Christophe HennequinCEA, Direction de la Recherche Fondamentale (DRF), Service de Recherche en Hemato-Immunologie (SRHI), Paris, France;Universite Paris Diderot, Sorbonne Paris Cite, IUH, Hopital Saint-Louis, UMR_E5, Paris, France;Service de Radiothérapie, AP-HP, Hopital Saint-Louis, Paris, France
,
François DesgrandchampsCEA, Direction de la Recherche Fondamentale (DRF), Service de Recherche en Hemato-Immunologie (SRHI), Paris, France;Universite Paris Diderot, Sorbonne Paris Cite, IUH, Hopital Saint-Louis, UMR_E5, Paris, France;Service d'Urologie, AP-HP, Hopital Saint-Louis, Paris, France
&
Edgardo D. CarosellaCEA, Direction de la Recherche Fondamentale (DRF), Service de Recherche en Hemato-Immunologie (SRHI), Paris, France;Universite Paris Diderot, Sorbonne Paris Cite, IUH, Hopital Saint-Louis, UMR_E5, Paris, FranceCorrespondence[email protected]
 show all
Article: e1342023 | Received 01 Feb 2017, Accepted 07 Jun 2017, Published online: 18 Jul 2017

Citations (37)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Albert Jang, Jake N. Lichterman, Jeffrey Y. Zhong, Jonathan E. Shoag, Jorge A. Garcia, Tian Zhang & Pedro C. Barata. (2023) Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma. Human Vaccines & Immunotherapeutics 19:3.
Read now

Articles from other publishers (36)

Sepideh Maralbashi, Cynthia Aslan, Houman Kahroba, Milad Asadi, Mohammad Sadegh Soltani-Zangbar, Navideh Haghnavaz, Farhad Jadidi, Farhad Salari & Tohid Kazemi. (2024) Docosahexaenoic acid (DHA) impairs hypoxia-induced cellular and exosomal overexpression of immune-checkpoints and immunomodulatory molecules in different subtypes of breast cancer cells. BMC Nutrition 10:1.
Crossref
Vladimira Durmanova, Miroslav Tedla, Dusan Rada, Helena Bandzuchova, Daniel Kuba, Magda Suchankova, Agata Ocenasova & Maria Bucova. (2024) Analysis of HLA-G 14 bp Insertion/Deletion Polymorphism and HLA-G, ILT2 and ILT4 Expression in Head and Neck Squamous Cell Carcinoma Patients. Diseases 12:2, pages 34.
Crossref
Siyuan Wang, Jiaxin Wang, Yu Xia, Le Zhang, Yueqiang Jiang, Man Liu, Qinglei Gao & Cuntai Zhang. (2024) Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects. Journal of Translational Medicine 22:1.
Crossref
Damián E. Moavro, Laura Andrini, Ailén Iribarne, Pablo Colaci & Marcela García. (2023) HLA-G expression in transitional bladder carcinoma. Relationship with tumor invasion level and patient survival: Experience in a public hospital in Argentina. Human Immunology 84:8, pages 423-427.
Crossref
Sanaa EL Marsafy & Jérôme Larghero. (2023) Cancer Cell De-Differentiation: Plasticity-Driven Stratagem For Tumor Metastasis and Recurrence. Current Stem Cell Research & Therapy 18:1, pages 54-61.
Crossref
Miguel Hernández-Bronchud. (2022) Redeployment of Placental Gene Programming: Can Invasive Placentation Molecular Switches Complement the Hallmarks of Cancer?. Journal of Clinical and Medical Research.
Crossref
Yu-Wei Chen, Brian I. Rini & Kathryn E. Beckermann. (2022) Emerging Targets in Clear Cell Renal Cell Carcinoma. Cancers 14:19, pages 4843.
Crossref
Qiong-Yuan Chen, Wen-Jun Zhou, Jiang-Gang Zhang, Xia Zhang, Qiu-Yue Han, Aifen Lin & Wei-Hua Yan. (2022) Prognostic significance of the immune checkpoint HLA-G/ILT-4 in the survival of patients with gastric cancer. International Immunopharmacology 109, pages 108798.
Crossref
Leonard Lugand, Guillaume Mestrallet, Rebecca Laboureur, Clement Dumont, Fatiha Bouhidel, Malika Djouadou, Alexandra Masson-Lecomte, Francois Desgrandchamps, Stephane Culine, Edgardo D. Carosella, Nathalie Rouas-Freiss & Joel LeMaoult. (2022) Methods for Establishing a Renal Cell Carcinoma Tumor Spheroid Model With Immune Infiltration for Immunotherapeutic Studies. Frontiers in Oncology 12.
Crossref
Hui-Hui Xu, Hui-Li Wang, Tong-Jin Xing & Xue-Quan Wang. (2022) A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes. Frontiers in Immunology 13.
Crossref
Diana Tronik-Le Roux, Marina Daouya, Alix Jacquier, Chantal Schenowitz, François Desgrandchamps, Nathalie Rouas-Freiss & Edgardo D. Carosella. (2022) The HLA-G immune checkpoint: a new immuno-stimulatory role for the α1-domain-deleted isoform. Cellular and Molecular Life Sciences 79:6.
Crossref
Simon Jasinski-Bergner, Markus Eckstein, Helge Taubert, Sven Wach, Christian Fiebig, Reiner Strick, Arndt Hartmann & Barbara Seliger. (2022) The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological Tumors. Frontiers in Immunology 13.
Crossref
Calvin D. De Louche & Ali Roghanian. (2022) Human inhibitory leukocyte Ig-like receptors: from immunotolerance to immunotherapy. JCI Insight 7:2.
Crossref
Lillian L. Siu, Ding Wang, John Hilton, Ravit Geva, Drew Rasco, Ruth Perets, Anson K. Abraham, Douglas C. Wilson, Julia F. Markensohn, Jared Lunceford, Leah Suttner, Shabana Siddiqi, Rachel A. Altura & Corinne Maurice-Dror. (2022) First-in-Class Anti-immunoglobulin–like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors. Clinical Cancer Research 28:1, pages 57-70.
Crossref
Alix Jacquier, Tiphaine Lambert, Jean-François Delattre, Malika Djouadou, Jérôme Vérine, Clément Dumont, François Desgrandchamps, Edgardo D. Carosella, Joel LeMaoult & Nathalie Rouas-Freiss. (2021) Tumor infiltrating and peripheral CD4+ILT2+ T cells are a cytotoxic subset selectively inhibited by HLA-G in clear cell renal cell carcinoma patients. Cancer Letters 519, pages 105-116.
Crossref
Christian Vaquero-Yuste, Ignacio Juarez, Marta Molina-Alejandre, Elisa María Molanes-López, Adrián López-Nares, Fabio Suárez-Trujillo, Alberto Gutiérrez-Calvo, Adela López-García, Inmaculada Lasa, Remedios Gómez, Eduardo Fernández-Cruz, Carmen Rodrígez-Sainz, Antonio Arnaiz-Villena & José Manuel Martín-Villa. (2021) HLA-G 3’UTR Polymorphisms Are Linked to Susceptibility and Survival in Spanish Gastric Adenocarcinoma Patients. Frontiers in Immunology 12.
Crossref
Ahmet Hazini, Kerry Fisher & Len Seymour. (2021) Deregulation of HLA-I in cancer and its central importance for immunotherapy. Journal for ImmunoTherapy of Cancer 9:8, pages e002899.
Crossref
Ricky B. van de Water, Daniëlle Krijgsman, Ruben D. Houvast, Alexander L. Vahrmeijer & Peter J. K. Kuppen. (2021) A Critical Assessment of the Association between HLA-G Expression by Carcinomas and Clinical Outcome. International Journal of Molecular Sciences 22:15, pages 8265.
Crossref
Hui-Hui Xu, Jun Gan, Dan-Ping Xu, Lu Li & Wei-Hua Yan. (2021) Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers. Frontiers in Immunology 12.
Crossref
Aifen Lin & Wei-Hua Yan. (2021) HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges. Frontiers in Immunology 12.
Crossref
Andrea Ziblat, Ximena Lucía Raffo Iraolagoitia, Sol Yanel Nuñez, Nicolás Ignacio Torres, Florencia Secchiari, Jessica Mariel Sierra, Raúl Germán Spallanzani, Agustín Rovegno, Fernando Pablo Secin, Mercedes Beatriz Fuertes, Carolina Inés Domaica & Norberto Walter Zwirner. (2021) Circulating and Tumor-Infiltrating NK Cells From Clear Cell Renal Cell Carcinoma Patients Exhibit a Predominantly Inhibitory Phenotype Characterized by Overexpression of CD85j, CD45, CD48 and PD-1. Frontiers in Immunology 12.
Crossref
Xiaoyang Wang, Robert Lopez, Rebecca A. Luchtel, Sassan Hafizi, Benjamin Gartrell & Niraj Shenoy. (2021) Immune evasion in renal cell carcinoma: biology, clinical translation, future directions. Kidney International 99:1, pages 75-85.
Crossref
Marcela García, Maria Belen Palma, Jerome Verine, Santiago Miriuka, Ana M. Inda, Ana L. Errecalde, François Desgrandchamps, Edgardo D. Carosella & Diana Tronik-Le Roux. (2020) The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma. BMC Cancer 20:1.
Crossref
Xia Zhang, Aifen Lin, Qiu-Yue Han, Jian-Gang Zhang, Qiong-Yuan Chen, Yao-Han Ye, Wen-Jun Zhou, Hui-Hui Xu, Jun Gan & Wei-Hua Yan. (2020) Intratumor Heterogeneity of HLA-G Expression in Cancer Lesions. Frontiers in Immunology 11.
Crossref
Maria Loustau, François Anna, Raphaelle Dréan, Martin Lecomte, Pierre Langlade-Demoyen & Julien Caumartin. (2020) HLA-G Neo-Expression on Tumors. Frontiers in Immunology 11.
Crossref
Diana Tronik-Le Roux, Mathilde Sautreuil, Mahmoud Bentriou, Jérôme Vérine, Maria Belén Palma, Marina Daouya, Fatiha Bouhidel, Sarah Lemler, Joel LeMaoult, François Desgrandchamps, Paul-Henry Cournède & Edgardo D. Carosella. (2020) Comprehensive landscape of immune-checkpoints uncovered in clear cell renal cell carcinoma reveals new and emerging therapeutic targets. Cancer Immunology, Immunotherapy 69:7, pages 1237-1252.
Crossref
Daniëlle Krijgsman, Jessica Roelands, Wouter Hendrickx, Davide Bedognetti & Peter J. K. Kuppen. (2020) HLA-G: A New Immune Checkpoint in Cancer?. International Journal of Molecular Sciences 21:12, pages 4528.
Crossref
Hui-Hui Xu, Wei-Hua Yan & Aifen Lin. (2020) The Role of HLA-G in Human Papillomavirus Infections and Cervical Carcinogenesis. Frontiers in Immunology 11.
Crossref
Yongchang Lai, Tao Zeng, Xiongfa Liang, Weizou Wu, Fangling Zhong & Wenqi Wu. (2019) Cell death-related molecules and biomarkers for renal cell carcinoma targeted therapy. Cancer Cell International 19:1.
Crossref
Clement Dumont, Alix Jacquier, Jerome Verine, Floriane Noel, Annabelle Goujon, Ching-Lien Wu, Tzu-Min Hung, François Desgrandchamps, Stephane Culine, Edgardo D. Carosella, Nathalie Rouas-Freiss & Joel LeMaoult. (2019) CD8+PD-1–ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-G. Cancer Immunology Research 7:10, pages 1619-1632.
Crossref
Aifen Lin & Wei-Hua Yan. (2019) The Emerging Roles of Human Leukocyte Antigen-F in Immune Modulation and Viral Infection. Frontiers in Immunology 10.
Crossref
Zhaoyang Cai, Lu Wang, Yali Han, Wenwen Gao, Xiaojuan Wei, Rumei Gong, Mingliang Zhu, Yuping Sun & Shuwen Yu. (2019) Immunoglobulin‑like transcript 4 and human leukocyte antigen‑G interaction promotes the progression of human colorectal cancer. International Journal of Oncology.
Crossref
Hui Li, Jun‐Quan Xia, Fang‐Shi Zhu, Zhao‐Hong Xi, Cheng‐Yu Pan, Li‐Mei Gu & Yao‐Zhou Tian. (2018) LPS promotes the expression of PD‐L1 in gastric cancer cells through NF‐κB activation. Journal of Cellular Biochemistry 119:12, pages 9997-10004.
Crossref
Aifen Lin & Wei-Hua Yan. (2018) Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges. Frontiers in Immunology 9.
Crossref
Dale I. Godfrey, Jérôme Le Nours, Daniel M. Andrews, Adam P. Uldrich & Jamie Rossjohn. (2018) Unconventional T Cell Targets for Cancer Immunotherapy. Immunity 48:3, pages 453-473.
Crossref
Rui-Li Zhang, Xia Zhang, Shan-Shan Dong, Bing Hu, Qiu-Yue Han, Jian-Gang Zhang, Wen-Jun Zhou, Aifen Lin & Wei-Hua Yan. (2017) Predictive value of different proportion of lesion HLA-G expression in colorectal cancer. Oncotarget 8:64, pages 107441-107451.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.